Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Will Johnson & Johnson Stock Hit $300 This Year? - AOL
Westerkirk Capital Inc. Buys 5,000 Shares of Johnson & Johnson $JNJ
Focus Partners Advisor Solutions LLC Grows Stake in Johnson & Johnson $JNJ
Winnow Wealth LLC Sells 3,827 Shares of Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson $JNJ Holdings Raised by Cerity Partners LLC
Johnson & Johnson Update: Wave 4 Correction May Be Nearing Completion After Wave 3 Extension
Capital International Sarl Makes New Investment in Johnson & Johnson $JNJ
TIAA Trust National Association Has $69.71 Million Stake in Johnson & Johnson $JNJ - Stock Observer
Westerkirk Capital Inc. Increases Holdings in Johnson & Johnson $JNJ - Daily Political
The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000
Promising Medical Stocks To Research - June 8th - Stock Observer
Johnson & Johnson to Buy Firefly Bio for $1 Billion | Morningstar
Johnson & Johnson To Acquire Firefly Bio To Expand Oncology Pipeline
Johnson & Johnson (JNJ): A Cheap Robotics Stock Redefining Coronary Artery Disease Treatment
10,175 Shares in Johnson & Johnson $JNJ Bought by Hilton Head Capital Partners LLC - Markets Daily
Hilton Head Capital Partners LLC Purchases Shares of 10,175 Johnson & Johnson $JNJ - Zolmax
LPL Financial LLC Buys 54,322 Shares of Johnson & Johnson $JNJ
Fiera Capital Corp Reduces Stake in Johnson & Johnson $JNJ - Markets Daily
Fiera Capital Corp Sells 187,171 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Position Increased by Capital International Inc. CA
Johnson & Johnson $JNJ Shares Sold by O Shaughnessy Asset Management LLC - Daily Political
Franklin Resources Inc. Sells 5,342,443 Shares of Johnson & Johnson $JNJ - Daily Political
Best Medical Stocks To Research - June 7th - Stock Observer
XML Financial LLC Has $13.12 Million Stock Position in Johnson & Johnson $JNJ - Markets Daily
XML Financial LLC Has $13.12 Million Position in Johnson & Johnson $JNJ - Zolmax
Los Angeles Capital Management LLC Purchases 255,236 Shares of Johnson & Johnson $JNJ - Markets Daily
Johnson & Johnson $JNJ Shares Sold by ING Groep NV
Havemeyer Place LP Purchases Shares of 10,134 Johnson & Johnson $JNJ
Clearbridge Investments LLC Has $1.16 Billion Stock Holdings in Johnson & Johnson $JNJ - Zolmax
Capital World Investors Invests $2.01 Billion in Johnson & Johnson $JNJ
Johnson & Johnson (NYSE:JNJ) - Stock Analysis - Simply Wall St
Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock - AOL
Johnson And Johnson ASCO 2026 Data Adds Depth To JNJ Valuation Story
Johnson & Johnson (JNJ) Jury Rules in Favor of Company in Talc Lawsuit
Best Medical Stocks To Follow Now - June 5th - Markets Daily
Vestcor Inc Boosts Stock Position in Johnson & Johnson $JNJ
Healthcare Stocks To Keep An Eye On - June 6th - Daily Political
102,246 Shares in Johnson & Johnson $JNJ Bought by PBU The Pension Fund of Early Childhood & Youth Educators - Zolmax
111 Capital Makes New $1.74 Million Investment in Johnson & Johnson $JNJ
Arsenal Capital Advisors LLC Takes Position in Johnson & Johnson $JNJ
111 Capital Purchases Shares of 8,416 Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson beats lawsuit alleging that talc caused 3 women's cancer | The Straits Times
PBU The Pension Fund of Early Childhood & Youth Educators Buys New Position in Johnson & Johnson $JNJ - Daily Political
J&J beats lawsuit alleging that talc caused three women's cancer
Johnson & Johnson (NYSE:JNJ) Stock Price Up 2% - Still a Buy? - Zolmax
Johnson & Johnson (NYSE:JNJ) Shares Up 2% - Still a Buy?
Erste Group downgrades Deutsche Telekom (0MPH) to a Hold
Johnson & Johnson (JNJ) Gets a Buy from Guggenheim
Jim Cramer Highlights Johnson & Johnson Having No Big Patent Expirations
Is It Time To Reassess Johnson & Johnson (JNJ) After A 52% One-Year Surge? - Simply Wall St News
Johnson & Johnson $JNJ Shares Sold by J.W. Cole Advisors Inc. - Zolmax
Dividend Aristocrats on Sale: 5 Decades-Long Raisers Trading Below Target
Total Wealth Planning & Management Inc. Takes $1.03 Million Position in Johnson & Johnson $JNJ - Zolmax
4,997 Shares in Johnson & Johnson $JNJ Bought by Total Wealth Planning & Management Inc.
313,929 Shares in Johnson & Johnson $JNJ Acquired by Arrowpoint Investment Partners Singapore Pte. Ltd.
Daiwa Securities Group Inc. Grows Position in Johnson & Johnson $JNJ - Stock Observer
Prudential PLC Has $81.29 Million Stock Holdings in Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson $JNJ Shares Purchased by Deseret Mutual Benefit Administrators - Stock Observer
Vise Technologies Inc. Has $20.93 Million Stock Holdings in Johnson & Johnson $JNJ - Daily Political
Prestige Wealth Management Group LLC Has $7.04 Million Position in Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson (NYSE:JNJ) Trading 2.3% Higher - Time to Buy?
JNJ: Future Drug Cycle Momentum Is Expected To Drive Returns
Jim Cramer's 5 Stock Calls, Including Alphabet and Eli Lilly, and Possible Opportunities
Top Healthcare Stocks To Add to Your Watchlist - June 4th - Zolmax
This Dividend King Is the Safest Dow Stock to Buy and Hold for 20 Years
Johnson And Johnson Autoimmune Trial Data And What It Means For JNJ
TD Asset Management Inc Increases Stock Holdings in Johnson & Johnson $JNJ
WCG Wealth Advisors LLC Acquires 22,434 Shares of Johnson & Johnson $JNJ
Greenspring Advisors LLC Purchases Shares of 7,353 Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Position Boosted by Cibc World Market Inc.
Platform Wealth Management LLC Takes Position in Johnson & Johnson $JNJ - Stock Observer
Greenspring Advisors LLC Makes New Investment in Johnson & Johnson $JNJ - Stock Observer
First-in-India: Johnson & Johnson Receives Approval for VARIPULSE™ Platform, Advancing Atrial Fibrillation Treatment | Hindustan Times
Cibc World Market Inc. Acquires 70,817 Shares of Johnson & Johnson $JNJ - Stock Observer
Paul Hastings Settles With J&J Unit in Bankruptcy Fee Dispute
Mawer Investment Management Ltd. Acquires 14,220 Shares of Johnson & Johnson $JNJ - Zolmax
Vantus Wealth LLC Makes New $995,000 Investment in Johnson & Johnson $JNJ
Johnson & Johnson (JNJ) Reports Positive Results for Lupus Treatment Nipocalimab
Johnson & Johnson (JNJ) Reveals Promising Data for Sjogren's Disease Treatment
Kesler Norman & Wride LLC Sells 38,128 Shares of Johnson & Johnson $JNJ
One Capital Management LLC Sells 33,786 Shares of Johnson & Johnson $JNJ
First-in-India: Johnson & Johnson Receives Approval for VARIPULSE™ Platform, Advancing Atrial Fibrillation Treatment
Johnson & Johnson (JNJ) Stock Rises on Positive Nipocalimab Lupus Trial Data
Johnson & Johnson $JNJ Shares Purchased by CIBC Asset Management Inc
Bank of New York Mellon Corp Cuts Stake in Johnson & Johnson $JNJ
Johnson & Johnson (JNJ) Reports Positive Phase 2 Results for Lupus Treatment
JNJ's Nipocalimab Meets Primary Goal In Phase 2 JASMINE Trial Of Systemic Lupus Erythematosus
Johnson & Johnson $JNJ Shares Sold by Westpac Banking Corp - Daily Political
A Look At Johnson & Johnson (JNJ) Valuation After Recent Share Price Weakness - Simply Wall St News
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study | Morningstar
JnJ News
US May CPI Report: A Key Inflation Gauge and Interest Rate Implications
Trump and Netanyahu's Strained Alliance: Open Disagreements Amidst Political Pressures
Iran's Strategic Pivot: From Proxy Warfare to Direct Confrontation with Israel
Oracle Q4 Earnings Preview: AI Momentum and Cloud Infrastructure Under Scrutiny
US CPI Preview: Higher Inflation Could Reinforce Fed Rate-Hike Bets
CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts
Latest news
Show moreBank of Canada Holds Rates Steady at 2.25%: Navigating the Economic Tightrope
US CPI Outlook: Inflation Fears Rise Amid Energy Shocks and Policy Uncertainty
US Inflation Surges, Core Prices Show Resilience; Fed Policy Outlook Under Scrutiny
US Intelligence Agency Elevates Israel Threat Level Amid Espionage Concerns
US Vice President Vance Expresses Confidence in Trump's Ability to Avoid Prolonged Iran Conflict
